<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-9.anc" start="18627" end="18633" sStart="18569" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" text="Nevertheless, these data demonstrate that a short &lt;b&gt;window&lt;/b&gt; of opportunity to contain viral infection following mucosal exposure exists and that potentiating the effectiveness of the mucosal natural barrier by local immunization may further limit or halt viral replication." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="15611" end="15616" sStart="null" offset="46" sid="r7.1.use.v.0127" wn="1" wnkey="use%2:34:01::" text="Here we conducted a small pilot study using genetically defined Mamu-A*01 macaques to study the vims-specific immune response following parenteral or rectal exposure to SIV mac251 This study was designed to begin to investigate the specificity of the immune response and its kinetics as well as the kinetics of viral replication according to the site of primary exposure and viral entry." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="18303" end="18307" sStart="null" offset="107" sid="r11.true.j.0355" wn="1" wnkey="true%3:00:00::" text="The differences in the relative percentage of homing markers may not necessarily reflect a true qualitative difference in the overall lymphocyte trafficking related to the mode of viral encounter and may depend on the time of analysis, since the kinetic of viral replication was delayed in the macaque exposed intrarectally." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="19255" end="19264" sStart="null" offset="167" sid="r8.suggest.v.0433" wn="1" wnkey="suggest%2:32:00::" text="In particular, since a CD8+ T-cell response to Tat appears to be the earliest, this protein may be a key component of a preventive vaccine, as suggested by other [ 35][ 36, 37, 43]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-9.anc" start="1069" end="1074" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="Despite the &lt;b&gt;rapid&lt;/b&gt; dissemination of HIV-I by mucosal routes, productive mucosal transmission appears to be relatively inefficient and is estimated to occur once in 300 or more high-risk exposures [ 17]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-9.anc" start="1069" end="1074" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Despite the &lt;b&gt;rapid&lt;/b&gt; dissemination of HIV-I by mucosal routes, productive mucosal transmission appears to be relatively inefficient and is estimated to occur once in 300 or more high-risk exposures [ 17]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="19091" end="19101" sStart="null" offset="3" sid="r10.particular.j.0204" wn="2147483645" wnkey="null" text="In particular, since a CD8+ T-cell response to Tat appears to be the earliest, this protein may be a key component of a preventive vaccine, as suggested by other [ 35][ 36, 37, 43]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="15004" end="15009" sStart="null" offset="39" sid="r9.level.n.0198" wn="1" wnkey="level%1:07:00::" text="The finding that the highest level of CD8+ T-cells with proliferative ability was in the lamina propria of the jejunum of animal 817 challenged intrarectally is suggestive of a qualitative difference of CD8+ T-cells present at the site of induction and of heterogeneity in the virus-specific CD8+ response." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="6459" end="6470" sStart="null" offset="49" sid="r11.combination.n.0396" wn="1" wnkey="combination%1:14:00::" text="In addition, cells were stained with a combination of anti-CD3 PerCP, anti-CD8 FITC and anti CD4 PE (Becton Dickinson, San Jose, CA) . To assess their proliferative ability and to confirm the specificity of tetramer staining of ex vivo CD3+ CD8+ T-cells, lymphocytes were cultured at a concentration of 3 ? 10 6/ml in RPMI enriched with 10% human serum with addition of 10 ?g/ml of the appropriate peptide and 20 U/ml of IL-2 for 7 days." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="18943" end="18950" sStart="null" offset="63" sid="r9.appear.v.0359" wn="4" wnkey="appear%2:39:01::" text="In fact, in a previous study, we have observed that it appears to be easier to protect vaccinated macaques by intrarectal exposure than intravenous exposure to SIV 251 [ 42]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-9.anc" start="11429" end="11436" sStart="null" offset="0" sid="r11.absence.n.0426" wn="1" wnkey="absence%1:26:00::" text="Absence of CD4+ T-cell depletion in the GALT of Mamu-A*01 macaques" />
  </sentences>
</list>